| |
| |
|
| Insider
Information: |
Matsui Connie |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
273,009 |
|
|
Indirect Shares
|
40,766 |
|
|
| Direct
Value |
$13,423,442 |
|
|
|
Indirect Value
|
$9,029,669 |
|
|
| Total
Shares |
313,775 |
|
|
| Total
Value |
$22,453,111 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
2.0
|
| Percentage
Gain/Loss : |
 -16.5%
|
 66.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
EVP, Corp. Strategy an... |
2007-02-12 |
22,837 |
2007-02-12 |
40,766 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
|
2024-04-25 |
193,505 |
|
0 |
Premium* |
|
|
Artelo Biosciences, Inc. |
ARTL |
|
2020-05-04 |
56,667 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2004-08-20 |
4 |
S |
$58.98 |
$4,722,780 |
D/D |
(80,000) |
7,998 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2005-01-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
993 |
11,667 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2005-10-12 |
4/A |
AS |
$36.36 |
$1,414,625 |
D/D |
(38,771) |
11,667 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2006-07-17 |
4 |
AS |
$42.47 |
$1,706,568 |
D/D |
(40,000) |
12,344 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2004-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
158,291 |
12,660 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2006-07-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,000 |
|
- |
|
| ARTL |
Artelo Biosciences, Inc. |
|
– • – |
2019-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,000 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2007-02-06 |
4 |
D |
$48.94 |
$287,180 |
D/D |
(5,868) |
18,537 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2006-09-14 |
4 |
D |
$43.39 |
$347,380 |
D/D |
(8,006) |
22,571 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2006-10-16 |
4 |
AS |
$45.43 |
$1,820,354 |
D/D |
(40,000) |
22,571 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2007-01-16 |
4 |
AS |
$50.83 |
$1,261,696 |
D/D |
(24,823) |
22,571 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2007-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
4,300 |
22,837 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2007-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,834 |
24,405 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-05-15 |
4 |
A |
$10.37 |
$155,550 |
D/D |
15,000 |
30,000 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2006-09-14 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
30,577 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
officerTitle |
• – – |
2005-10-12 |
4/A |
AS |
$36.36 |
$1,322,346 |
I/I |
(36,229) |
39,610 |
|
- |
|
| BIIB |
Biogen Idec Inc |
officerTitle |
• – – |
2005-12-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,289 |
40,766 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2008-05-08 |
4 |
A |
$4.94 |
$74,100 |
D/D |
15,000 |
45,000 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2007-01-16 |
4 |
OE |
$6.92 |
$185,189 |
D/D |
24,823 |
47,394 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2005-10-12 |
4/A |
OE |
$7.72 |
$299,266 |
D/D |
38,771 |
50,438 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2006-07-17 |
4 |
OE |
$7.72 |
$308,752 |
D/D |
40,000 |
52,344 |
|
- |
|
| ARTL |
Artelo Biosciences, Inc. |
|
– • – |
2020-05-04 |
4 |
B |
$1.20 |
$50,000 |
D/D |
41,667 |
56,667 |
0.01 |
% |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2006-10-16 |
4 |
OE |
$7.72 |
$308,752 |
D/D |
40,000 |
62,571 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2009-05-07 |
4 |
A |
$0.00 |
$20 |
D/D |
20,000 |
65,000 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2005-07-12 |
4 |
AS |
$36.19 |
$2,897,573 |
I/I |
(80,000) |
79,284 |
|
- |
|
65 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
